"10.1371_journal.pone.0108205","plos one","2014-10-01T00:00:00Z","Marika Pane; Elena Stacy Mazzone; Serena Sivo; Maria Pia Sormani; Sonia Messina; Adele D′Amico; Adelina Carlesi; Gianluca Vita; Lavinia Fanelli; Angela Berardinelli; Yvan Torrente; Valentina Lanzillotta; Emanuela Viggiano; Paola D′Ambrosio; Filippo Cavallaro; Silvia Frosini; Andrea Barp; Serena Bonfiglio; Roberta Scalise; Roberto De Sanctis; Enrica Rolle; Alessandra Graziano; Francesca Magri; Concetta Palermo; Francesca Rossi; Maria Alice Donati; Michele Sacchini; Maria Teresa Arnoldi; Giovanni Baranello; Tiziana Mongini; Antonella Pini; Roberta Battini; Elena Pegoraro; Stefano Previtali; Claudio Bruno; Luisa Politano; Giacomo P Comi; Enrico Bertini; Eugenio Mercuri","Department of Paediatric Neurology, Catholic University, Rome, Italy; Biostatistics Unit, Department of Health Sciences, University of Genoa, Genoa, Italy; Department of Neurosciences, Psychiatry and Anaesthesiology, University of Messina, Messina, Italy; Department of Neurosciences, Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Childrens Hospital, Rome, Italy; Child Neurology and Psychiatry Unit, Casimiro Mondino Foundation, Pavia, Italy; Dino Ferrari Centre, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, Neurology Unit, Ca Granda Ospedale Maggiore Policlinico, Milan, Italy; Neuromuscular Disease Unit, Giannina Gaslini Institute, Genoa, Italy; Dipartimento di Medicina Sperimentale, Seconda Università di Napoli, Napoli, Italy; Department of Developmental Neuroscience, Stella Maris Institute, Pisa, Italy; Department of Neurosciences, University of Padua, Padua, Italy; Child Neurology and Psychiatry Unit, Maggiore Hospital, Bologna, Italy; Neuromuscular Center, San Giovanni Battista Hospital, University of Turin, Turin, Italy; Metabolic and Neuromuscular Unit, Meyer Hospital, Florence, Italy; Developmental Neurology Unit, Neurological Institute Carlo Besta, Milan, Italy; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy","Conceived and designed the experiments: MP ESM SS LF RDS EM. Performed the experiments: SM LF RDS VL FC ER SF MTA FR. Analyzed the data: MP ESM SS MPS SM AD AC GV AB YT VL EV PD FC SF AB SB CP RS RDS ER AG FM MAD MS MTA FR GB TM AP RB EP SP CB LP GPC EB EM. Wrote the paper: MP ESM SS MPS SM AD AC GV LF AB YT VL EV PD FC SF AB SB CP RS RDS ER AG FM MAD MS MTA FR GB TM AP RB EP SP CB LP GPC EB EM.","Dr. Pane, Dr. Sivo and E. Mazzone report no disclosures. Dr. Sormani: serves on a scientific advisory board for Biogen Idec.; has received funding for travel or speaker honoraria from Merck Serono; serves as consultant for Merck Serono, Actelion Pharmaceuticals Lts. Biogen Idec, and Synthon; and serves on the speakers bureaus of Teva Pharmaceutical Industries Ltd., Merck Serono, and Biogen Idec. Dr. DAmico and Dr. Messina report no disclosures. Dr. Vita serves as an Associate Editor for Neurological Sciences. L. Fanelli, Dr. Berardinelli, Dr. Torrente, V. Lanzillotta, Dr. Viggiano, Dr. DAmbrosio, F. Cavallaro, S. Frosini, Dr. Barp, Dr. Bonfiglio, Dr. Scalise, R. De Sanctis, E. Rolle, Dr. Graziano, Dr. Magri, Dr. Palermo, F. Rossi, Dr. Donati, Dr. Sacchini, Dr. Arnoldi, Dr. Baranello report no disclosures. Dr. Mongini has served on a scientific advisory board for Telethon Italy; has received funding for travel from Genzyme Corporation; and has received research support from AIFA (Italian Government Drug Agency) and Telethon Italy. Dr. Pini, Dr. Battini report no disclosures. Dr. Pegoraro has served on a scientific advisory board for BioMarin Pharmaceutical Inc.; has received funding for travel from Genzyme Corporation; and has received speaker honoraria from MedaPharma; and receives research support from Wellstone and Telethon Italy. Dr. Previtali, Dr. Bruno, Dr. Politano report no disclosures. Dr. Comi: is site PI for the PTC extension study of Ataluren in DMD, for the GSK study on exon skipping; receives research support from Telethon Italy and SMA Europe. Dr. Bertini is site PI for the PTC extension study of Ataluren in DMD, for the GSK study on exon skipping. He also receives funds from the Italian Telethon, the Italian Ministry of Health and SMA Europe for observational studies on outcome measures. Dr. Mercuri is site PI for the PTC extension study of Ataluren in DMD, for the GSK Prosensa and Sarepta studies on exon skipping. He also receives funds from the Italian Telethon and SMA Europe. He has acted as advisory board for Acceleron Pharma, Shire and PTC Therapeutics, Inc, Prosensa. The disclosures shown in the paper do not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","10","Marika Pane","MP",39,TRUE,6,9,37,38,TRUE,TRUE,FALSE,0,NA,FALSE
